CTNMContineum Therapeutics, Inc.
$8.29-25% 1Y
$8.29
$7.0952 weeks$17.56
Is the price fair?
What CTNM's price assumes
- Price / book
- 2.56
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 2.56
- Market capitalisation37.6 million shares, counted Jul 24, 2026
- $312M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Biotechnology
The closest names by size in the same industry